Author:
Adames Angela,O’Brien Diana Roth,Kelly Alison R.,Saltz Leonard B.,Garcia-Aguilar Julio,Zinovoy Melissa,Williams Vonetta,Wu Abraham,Reyngold Marsha,Hajj Carla,Crane Christopher,Cercek Andrea,Smith J. Joshua,Markova Alina,Cuaron John,McCann Patrick,Romesser Paul B.
Abstract
Abstract
Background
Palmar-plantar erythrodysesthesia (PPE) is a slowly developing cutaneous reaction commonly experienced by patients treated with fluoropyrimidines. While erythrodysesthesia normally presents in a palmar-plantar distribution, it can also present with genital involvement, but this presentation is likely underreported and incorrectly attributed to an acute reaction from radiation therapy. This article aims to define erythrodysesthesia of the penis and scrotum as a rare but significant side effect of capecitabine.
Case presentation
We identified five cases of moderate to severe penis and scrotal erythrodysesthesia over a 2-year period at a large tertiary cancer center, representing an estimated incidence of 3.6% among male patients with rectal cancer who were treated with fluoropyrimidine-based chemoradiation within our institution.
Conclusions
Improved understanding of erythrodysesthesia involving the penis and scrotum can facilitate early identification and treatment of symptoms, and possibly prevent the discontinuation or delay of cancer treatment in patients treated with capecitabine and similar drugs. These clinical advances would improve and prolong patient quality of life during cancer treatment and prevent complications that result in hospitalization.
Funder
National Institutes of Health
Publisher
Springer Science and Business Media LLC
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Capecitabine/fluorouracil;Reactions Weekly;2024-06-15